產(chǎn)品詳情
簡單介紹:
InterleukinEnhancerBindingFactor2,45kDa(ILF2)(N-Term)Peptide
詳情介紹:
Blocked Antibody | anti-ILF2 antibody (Interleukin Enhancer Binding Factor 2, 45kDa) (N-Term) (ABIN2780055) |
Sequence | KRNQDLAPNS AEQASILSLV TKINNVIDNL IVAPGTFEVQ IEEVRQVGSY |
Characteristics | This is a synthetic peptide designed for use in combination with anti-Ilf2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. |
Purification | Purified |
Background |
Ilf2 appears to function predominantly as a heterodimeric complex with ILF3. This complex may regulate transcription of the IL2 gene during T-cell activation. It can also promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA. Alias Symbols: 6230405A16Rik, TEG-267, Tex261, Tex267 Protein Size: 390 |
Molecular Weight | 42 kDa |
Gene ID | 67781 |
NCBI Accession | NM_026374, NP_080650 |
UniProt | Q9CXY6 |
Application Notes | Optimal working dilution should be determined by the investigator. |
Restrictions | For Research Use only |
Format | Lyophilized |
Reconstitution | Add 100?μL of sterile PBS. Final peptide concentration is 1?mg/mL in PBS. |
Concentration | 1 mg/mL |
Buffer | Final peptide concentration is 1 mg/mL in PBS. |
Handling Advice | Avoid repeat freeze-thaw cycles. |
Storage | -20 °C |
Storage Comment | For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles. |